MIM
QGEN icon

MetLife Investment Management’s Qiagen QGEN Stock Holding History

MetLife Investment Management’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$999K Buy
24,949
+348
+1% +$16.5K 0.01% 1394
2025
Q4 		$1.12M Sell
24,601
-66
-0.3% -$3.05K 0.01% 1362
2025
Q3 		$1.1M Buy
24,667
+2,342
+10% +$112K 0.01% 1390
2025
Q2 		$1.07M Sell
22,325
-4,819
-18% -$210K 0.01% 1270
2025
Q1 		$1.08M Sell
27,144
-1,607
-6% -$67.6K 0.01% 1328
2024
Q4 		$1.32M Buy
28,751
+5,481
+24% +$245K 0.01% 1281
2024
Q3 		$1.08M Sell
23,270
-42
-0.2% -$1.92K 0.01% 1349
2024
Q2 		$990K Buy
23,312
+7,387
+46% +$324K 0.01% 1353
2024
Q1 		$702K Sell
15,925
-39
-0.2% -$1.78K ﹤0.01% 1500
2023
Q4 		$737K Sell
15,964
-24
-0.2% -$1.02K 0.01% 1466
2023
Q3 		$687K Sell
15,988
-2,578
-14% -$120K 0.01% 1444
2023
Q2 		$884K Sell
18,566
-184
-1% -$8.87K 0.01% 1338
2023
Q1 		$907K Buy
18,750
+10
+0.1% +$509 0.01% 1263
2022
Q4 		$996K Buy
18,740
+21
+0.1% +$1.03K 0.01% 1214
2022
Q3 		$831K Sell
18,719
-106
-0.6% -$5.24K 0.01% 1285
2022
Q2 		$937K Buy
18,825
+227
+1% +$11.1K 0.01% 1237
2022
Q1 		$972K Buy
18,598
+4,279
+30% +$221K 0.01% 1346
2021
Q4 		$845K Hold
14,319
– – 0.01% 1203
2021
Q3 		$790K Hold
14,319
– – 0.01% 1256
2021
Q2 		$734K Hold
14,319
– – 0.01% 1348
2021
Q1 		$737K Sell
14,319
-2,840
-17% -$156K 0.01% 1298
2020
Q4 		$945K Hold
17,159
– – 0.01% 1163
2020
Q3 		$945K Hold
17,159
– – 0.01% 1054
2020
Q2 		$783K Buy
17,159
+2,857
+20% +$128K 0.01% 1130
2020
Q1 		$612K Hold
14,302
– – 0.01% 1112
2019
Q4 		$519K Hold
14,302
– – 0.01% 1445
2019
Q3 		$497K Hold
14,302
– – 0.01% 1425
2019
Q2 		$617K Sell
14,302
-287
-2% -$11.9K 0.01% 1361
2019
Q1 		$628K Buy
+14,589
New +$587K 0.01% 1322

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MetLife Investment Management's QGEN Position: Q1 2026 in Review

MetLife Investment Management increased its Qiagen (QGEN) stake by 1.4% in Q1 2026, buying an estimated $16.5K and bringing the position to 24,949 shares worth $999K. The position accounts for 0.01% of the portfolio, ranked #1394.

MetLife Investment Management first reported a position in QGEN in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.32M in Q4 2024. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • MetLife Investment Management held 24,949 shares of Qiagen worth $999K as of Q1 2026.
  • MetLife Investment Management bought 348 Qiagen shares in Q1 2026, an estimated $16.5K.
  • Qiagen made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1394 holding.
  • MetLife Investment Management first reported a position in Qiagen in Q1 2019 and has held it in 29 quarters since.
  • MetLife Investment Management's Qiagen position peaked at $1.32M in Q4 2024.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.